Clinical Study

Flow-Volume Parameters in COPD Related to Extended Measurements of Lung Volume, Diffusion, and Resistance

Table 3

Impulse oscillometry parameters.

ControlsGOLD1GOLD2GOLD3GOLD4

, kPa*/L0.27 (0.23–0.32)0.29 (0.26–0.31)0.37 (0.30–0.44)***†0.50 (0.39–0.67)***†††‡‡0.52 (0.41–0.70)***†††‡‡‡
%p90 (68–91)83 (74–97)105 (90–120)***†136 (121–195)***†††‡‡‡134 (126–173)***†††‡‡‡
, kPa*/L0.21 (0.18–0.26)0.22 (0.19–0.27)0.26 (0.20–0.28)0.30 (0.24–0.38)***††‡0.28 (0.25–0.34)**†
%p70 (62–89)79 (64–86)81 (73–96)*104 (85–130)***†††‡‡89 (79–99)**†
, kPa*/L0.04 (0.03–0.08)0.07 (0.03–0.10)0.12 (0.06–0.15)***†0.17 (0.12–0.33)***†††‡‡0.24 (0.17–0.36)***†††‡‡‡
%p100 (67–150)167 (75–192)250 (131–306)***†388 (281–554)***†††‡‡425 (367–650)***†††‡‡‡
AX, kPa*/L0.18 (0.13–0.44)0.16 (0.11–0.57)0.69 (0.34–1.49)***††1.64 (0.97–3.61)***†††‡‡3.17 (1.46–3.54)***†††‡‡‡
, Hz10.5 (8.9–14.6)12.5 (9.1–15.5)16.4 (13.9–19.9)***††20.4 (18.2–25.3)***†††‡23.9 (21.3–27.7)***†††‡‡‡#
X5, kPa*/L−0.09 (−0.11–−0.07)−0.08 (−0.12–−0.06)−0.14 (−0.22–−0.10)**†−0.25 (−0.43–−0.16)***†††‡‡−0.42 (−0.49–−0.23)***†††‡‡‡
X5 %p199 (104–312)175 (145–263)389 (182 –541)***†494 (447–795)***†††677 (501–859)***†††‡‡

Significant difference compared to healthy smokers, significant difference compared to GOLD1, significant difference compared to GOLD2, significant difference compared to GOLD3, one symbol flagging P < 0.05, two symbols flagging P < 0.01 and three symbols flagging P < 0.001. All data are presented as median (interquartile range).